- Home
- CDIO vs LUCY Comparison
CDIO vs LUCY Comparison
Compare CDIO & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- LUCY
- Stock Information
- Founded
- CDIO 2017
- LUCY 2017
- Country
- CDIO United States
- LUCY United States
- Employees
- CDIO N/A
- LUCY N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- LUCY Ophthalmic Goods
- Sector
- CDIO Health Care
- LUCY Health Care
- Exchange
- CDIO Nasdaq
- LUCY Nasdaq
- Market Cap
- CDIO 7.9M
- LUCY 8.9M
- IPO Year
- CDIO N/A
- LUCY 2022
- Fundamental
- Price
- CDIO $3.44
- LUCY $2.08
- Analyst Decision
- CDIO Buy
- LUCY
- Analyst Count
- CDIO 1
- LUCY 0
- Target Price
- CDIO $60.00
- LUCY N/A
- AVG Volume (30 Days)
- CDIO 57.8K
- LUCY 5.9M
- Earning Date
- CDIO 08-11-2025
- LUCY 08-11-2025
- Dividend Yield
- CDIO N/A
- LUCY N/A
- EPS Growth
- CDIO N/A
- LUCY N/A
- EPS
- CDIO N/A
- LUCY N/A
- Revenue
- CDIO $19,902.00
- LUCY $1,707,470.00
- Revenue This Year
- CDIO $1,434.82
- LUCY $367.48
- Revenue Next Year
- CDIO $4,661.91
- LUCY $166.67
- P/E Ratio
- CDIO N/A
- LUCY N/A
- Revenue Growth
- CDIO N/A
- LUCY 22.75
- 52 Week Low
- CDIO $3.22
- LUCY $1.57
- 52 Week High
- CDIO $53.10
- LUCY $13.20
- Technical
- Relative Strength Index (RSI)
- CDIO 32.36
- LUCY 42.33
- Support Level
- CDIO $3.65
- LUCY $1.95
- Resistance Level
- CDIO $4.18
- LUCY $4.97
- Average True Range (ATR)
- CDIO 0.31
- LUCY 0.35
- MACD
- CDIO 0.12
- LUCY -0.09
- Stochastic Oscillator
- CDIO 4.49
- LUCY 4.46
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.